Send Inquiry

Request To Call Back

Lapatinib Tablets IP 250mg

Get a Price/Quote

MOQ : 20 Packs

Lapatinib Tablets IP 250mg Specification

Dosage Form
Tablet

Origin of Medicine
India

Salt Composition
Lapatinib IP 250mg

Indication
HER2-positive breast cancer in combination with other therapies

Pacakaging (Quantity Per Box)
30 tablets per box

Drug Type
Allopathic

Ingredients
Lapatinib

Physical Form
Tablets

Function
Anti-cancer therapy (Tyrosine kinase inhibitor)

Recommended For
Advanced or metastatic breast cancer patients

Dosage
As directed by physician

Dosage Guidelines
Take with water, do not crush or chew, follow medical prescription

Suitable For
Adults

Quantity
30 tablets

Storage Instructions
Store below 30C, protected from moisture and light

Container Type
HDPE Bottle

Colour of Tablet
Yellow, film-coated

Shelf Life
24 months from date of manufacture

MRP
As per prevailing local regulations

Administration Route
Oral

Market Approval
Indian Pharmacopeia (IP) quality standard

Warning and Precaution
Use under strict medical supervision; pregnancy and breastfeeding not recommended

Brand Name
Lapatinib Tablets IP 250mg

Prescription Required
Yes

Side Effects
Rash, nausea, diarrhea, fatigue, hand-foot syndrome (consult doctor for full list)

Lapatinib Tablets IP 250mg Trade Information

Minimum Order Quantity
20 Packs

Supply Ability
Pack

Delivery Time
AS Per Order Week

About Lapatinib Tablets IP 250mg

Featured for its Marvelous efficacy, Lapatinib Tablets IP 250mg delivers lustrous results in advanced or metastatic breast cancer therapy. These classic yellow, film-coated tablets offer a sizzling edge in HER2-positive breast cancer treatment, working as a potent tyrosine kinase inhibitor. Available exclusively by prescription, Lapatinib is manufactured under Indian Pharmacopeia (IP) standards and handed over in HDPE bottles containing 30 tablets. With a shelf life of 24 months, these tablets must be stored below 30C and administered orally. Try now and experience a new way forward in cancer care.

Lapatinib Tablets IP 250mg: Usage and Competitive Edge

Lapatinib Tablets IP 250mg is administered orally and specifically recommended for adults with advanced or metastatic HER2-positive breast cancer. Its main application is as an anti-cancer therapy combined with other treatments. The primary competitive advantages include its IP-approved quality, classic film-coated formulation, and Marvelous results in targeted cancer care. Noteworthy is its reliable dosage, prescribed by healthcare professionals, ensuring safety and efficacy for adult patients under strict supervision.

Packaging, Availability, and Export Markets

Each box boasts stock ready, containing 30 lustrous yellow tablets housed in a secure HDPE bottle. Samples can be arranged for eligible clients, enhancing trust in product quality. Packaging ensures protection from moisture and light to maintain efficacy. Lapatinib Tablets IP 250mg is handed over promptly for domestic markets across India and has a sizzling presence in major export markets worldwide, reflecting the brands commitment as a reliable supplier, manufacturer, and exporter.

FAQs of Lapatinib Tablets IP 250mg:

Q: How should Lapatinib Tablets IP 250mg be administered for optimal effectiveness?

A: Lapatinib Tablets IP 250mg must be taken orally with water, following your physicians prescription. Do not crush or chew the tablets, and strictly adhere to the dosage guidelines provided.

Q: What conditions are Lapatinib Tablets IP 250mg indicated for?

A: Lapatinib Tablets are recommended for adults diagnosed with HER2-positive advanced or metastatic breast cancer, usually in combination with other cancer therapies.

Q: When is it necessary to consult a doctor while using Lapatinib Tablets?

A: Consult your doctor before starting treatment, and immediately if you experience serious side effects like rash, nausea, diarrhea, fatigue, or hand-foot syndrome. Only use under strict medical supervision.

Q: Where can Lapatinib Tablets IP 250mg be purchased or exported?

A: As a prescription drug, Lapatinib is available through authorized distributors, suppliers, and pharmacies in India. It is also stocked ready for international export through certified channels.

Q: What competitive benefits does Lapatinib Tablets IP 250mg offer compared to others?

A: Lapatinib provides Marvelous, IP-standard cancer care, with classic film-coated tablets, reliable shelf life, and trusted packaging, setting it apart as a premium choice for HER2-positive breast cancer management.

Q: What precautions should be taken during the usage of Lapatinib Tablets IP 250mg?

A: Use strictly under medical supervision, and avoid during pregnancy and breastfeeding. Store below 30C, protected from moisture and light, and follow your doctors directions for dosage and administration.

Tell us about your requirement

Price:

Quantity

Select Unit

50
100
200
250
500
1000+

Additional detail

Mobile number